0000899243-22-013342.txt : 20220404
0000899243-22-013342.hdr.sgml : 20220404
20220404162726
ACCESSION NUMBER: 0000899243-22-013342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Appelbaum Kevin J
CENTRAL INDEX KEY: 0001547557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39864
FILM NUMBER: 22802629
MAIL ADDRESS:
STREET 1: 4160 DUBLIN BLVD., SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended
CENTRAL INDEX KEY: 0001890904
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39864
FILM NUMBER: 22802628
BUSINESS ADDRESS:
STREET 1: 548 MARKET STREET, #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415.887.2311
MAIL ADDRESS:
STREET 1: 548 MARKET STREET, #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Better Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832415
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1028
BUSINESS ADDRESS:
STREET 1: 311 WEST 43RD STREET, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-493-6558
MAIL ADDRESS:
STREET 1: 311 WEST 43RD STREET, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II
DATE OF NAME CHANGE: 20201116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-31
0
0001832415
Better Therapeutics, Inc.
BTTX
0001547557
Appelbaum Kevin J
C/O BETTER THERAPEUTICS, INC.
548 MARKET STREET, #49404
SAN FRANCISCO
CA
94104
1
1
1
0
Chief Executive Officer
0001890904
Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended
C/O BETTER THERAPEUTICS, INC.
548 MARKET STREET, #49404
SAN FRANCISCO
CA
94104
0
0
1
0
Common Stock
2022-03-31
4
P
0
2500
1.9685
A
6250
D
Common Stock
2406719
I
By Trust
Stock Option (Right to Buy)
1.97
2022-04-01
4
A
0
235000
0.00
A
2032-03-31
Common Stock
235000
235000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.96 to $1.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.
The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
2022-04-04
/s/ Mark Heinen, Attorney-in-Fact for Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended
2022-04-04